The diverse effects of transforming growth factor-β and SMAD signaling pathways during the CTL response

Cytotoxic T lymphocytes (CTLs) play an important role in defense against infections with intracellular pathogens and anti-tumor immunity. Efficient migration is required to locate and destroy infected cells in different regions of the body. CTLs accomplish this task by differentiating into specialized subsets of effector and memory CD8 T cells that traffic to different tissues. Transforming growth factor-beta (TGFβ) belongs to a large family of growth factors that elicit diverse cellular responses via canonical and non-canonical signaling pathways. Canonical SMAD-dependent signaling pathways are required to coordinate changes in homing receptor expression as CTLs traffic between different tissues. In this review, we discuss the various ways that TGFβ and SMAD-dependent signaling pathways shape the cellular immune response and transcriptional programming of newly activated CTLs. As protective immunity requires access to the circulation, emphasis is placed on cellular processes that are required for cell-migration through the vasculature.

CTLs Get SMAD When Pathogens Tell Them Where to Go

Vaccines protect against infections by eliciting both Ab and T cell responses. Because the immunity wanes as protective epitopes get modified by accruing mutations, developing strategies for immunization against new variants is a major priority for vaccine development. CTLs eliminate cells that support viral replication and provide protection against new variants by targeting epitopes from internal viral proteins. This form of protection has received limited attention during vaccine development, partly because reliable methods for directing pathogen-specific memory CD8 T cells to vulnerable tissues are currently unavailable. In this review we examine how recent studies expand our knowledge of mechanisms that contribute to the functional diversity of CTLs as they respond to infection. We discuss the role of TGF-β and the SMAD signaling cascade during genetic programming of pathogen-specific CTLs and the pathways that promote formation of a newly identified subset of terminally differentiated memory CD8 T cells that localize in the vasculature.

SMAD4 and TGFβ are architects of inverse genetic programs during fate-determination of antiviral CTLs

Transforming growth factor β (TGFβ) is an important differentiation factor for cytotoxic T lymphocytes (CTLs) and alters the expression levels of several of homing receptors during infection. SMAD4 is part of the canonical signaling network used by members of the transforming growth factor family. For this study, genetically modified mice were used to determine how SMAD4 and TGFβ receptor II (TGFβRII) participate in transcriptional programming of pathogen-specific CTLs. We show that these molecules are essential components of opposing signaling mechanisms, and cooperatively regulate a collection of genes that determine whether specialized populations of pathogen-specific CTLs circulate around the body, or settle in peripheral tissues. TGFβ uses a canonical SMAD-dependent signaling pathway to downregulate Eomesodermin (EOMES), KLRG1, and CD62L, while CD103 is induced. Conversely, in vivo and in vitro data show that EOMES, KLRG1, CX₃CR1, and CD62L are positively regulated via SMAD4, while CD103 and Hobit are downregulated. Intravascular staining also shows that signaling via SMAD4 promotes formation of long-lived terminally differentiated CTLs that localize in the vasculature. Our data show that inflammatory molecules play a key role in lineage determination of pathogen-specific CTLs, and use SMAD-dependent signaling to alter the expression levels of multiple homing receptors and transcription factors with known functions during memory formation.

Localization of terminal memory CD8 T cells in the lungs during respiratory infection

Cytotoxic CD8 T cells (CTLs) play an important role in recovery from respiratory virus infection and provide protective immunity by targeting epitopes in well-conserved viral proteins that are shared by different strains of the virus. To provide immunity, CTLs migrate to different anatomical compartments in the lungs and destroy infected cells by injecting lytic molecules into the cytoplasm. Several adhesion molecules aid migration to the infected tissues and cytolysis. These molecules include killer lectin like receptor G1 (KLRG1), which is a membrane bound adhesion molecule that is expressed on terminally differentiated CD8 T effector (Teff) cells. Recently, several studies identified some long lived “terminal memory CD8 T cells (TTM)” that express KLRG1. The goal of our study is to determine the location of these TTM cells within the different compartments of the lungs during a respiratory infection. Our previous work showed that SMAD4 regulates several homing receptors on activated CTLs including KLRG1. We used transfer experiments to examine the distribution of WT cells that express SMAD4 and mutant CTLs that lack SMAD4 in the lungs. At 30 days after intranasal infection with Listeria monocytogenes, there were larger numbers of mutant CTLs in the airways (BAL fluid), while WT CTLs were primarily located in the lung tissue. Interestingly, the localization of the WT cells correlated with the expression of KLRG1. We are using in situ imaging to visualize these transferred CTLs during respiratory infection to better understand their role in protective immunity. Intravascular staining will be used to determine whether these CTLs remain in the blood vessels or enter the tissues of the infected recipient mice.

This work was supported by NIH Grant AI123864.

Tissue-resident memory T cell reactivation by diverse antigen-presenting cells imparts distinct functional responses

CD8⁺ tissue-resident memory T cells (T_RM cells) are poised at the portals of infection and provide long-term protective immunity. Despite their critical roles, the precise mechanics governing T_RM cell reactivation in situ are unknown. Using a TCR-transgenic Nur77-GFP reporter to distinguish “antigen-specific” from “bystander” reactivation, we demonstrate that lung CD8⁺ T_RM cells are reactivated more quickly, yet less efficiently, than their counterparts in the draining LNs (T_LN cells). Global profiling of reactivated memory T cells revealed tissue-defined and temporally regulated recall response programs. Unlike the reactivation of CD8⁺ T_LN cells, which is strictly dependent on CD11c⁺XCR1⁺ APCs, numerous antigen-presenting partners, both hematopoietic and non-hematopoietic, were sufficient to reactivate lung CD8⁺ T_RM cells, but the quality of T_RM cell functional responses depended on the identity of the APCs. Together, this work uncovers fundamental differences in the activation kinetics, mechanics, and effector responses between CD8⁺ memory T cells in peripheral vs. lymphoid organs, revealing a novel tissue-specific paradigm for the reactivation of memory CD8⁺ T cells.

Smad signaling determines the fate of activated CTLs via multiple intersecting signaling pathways

Immune responses to an infection are controlled by various factors including antigens, co-stimulatory molecules and cytokines present in the tissue micro-environment. TGFβ is a pleiotropic cytokine that modulates immune response and cellular differentiation usually through SMAD (Smad 2,3 & 4)-mediated signaling cascade. Interestingly, TGFβ and Smad4 have independent and opposing roles in determining the fate of activated CTLs. While TGFβ-receptor mediated signaling is required for resident memory (TRM) cells, Smad4 is required for effector (TEff) and central memory subsets (TCM). However, the mechanism behind TGFβ as well as Smad4 mediated differentiation is yet to be unraveled. Using transgenic animal models and pharmacological inhibitors, we investigate the role of TGFβ and multiple SMAD proteins in determining the fate of activated CTLs. We identified that while canonical TGFβ signaling, through Smad2 and Smad3, induces CD103 expression (TRM), Smad4 inhibits CD103 expression thus preventing TRM differentiation. In addition, targeted-ablation of Smad4 alters the expression of various transcription factors that participate in fate determination, including Eomes and KLF2. Although Eomes has previously been implicated in negative regulation of CD103, over-expression of Eomes does not affect CD103 expression in the absence of Smad4. This suggests that Smad4 is required for negative regulation of CD103. These results reveal a novel central role for Smad4 in guiding the fate decisions of activated CTLs and tissue localization via multiple intersecting signaling pathways.

Immunity to Respiratory Infection Is Reinforced Through Early Proliferation of Lymphoid TRM Cells and Prompt Arrival of Effector CD8 T Cells in the Lungs

Cross-protection between serologically distinct strains of influenza A virus (IAV) is mediated by memory CD8 T cells that recognize epitopes from conserved viral proteins. Early viral control begins with activation of tissue-resident memory CD8 T cells (T_RM) cells at the site of viral replication. These CD8 T cells do not act in isolation, as protection against disseminated infection is reinforced by multiple waves of effector cells (T_EFF) that enter the lungs with different kinetics. To define how a protective CTL response evolves, we compared the functional properties of antiviral CD8 T cells in the respiratory tract and local lymphoid tissues. When analyzed 30 dpi, large numbers of antiviral CD8 T cells in the lungs and mediastinal lymph nodes (MLNs) expressed canonical markers of T_RM cells (CD69 and/or CD103). The check point inhibitor PD-1 was also highly expressed on NP-specific CD8 T cells in the lungs, while the ratios of CD8 T cells expressing CD69 and CD103 varied according to antigen specificity. We next used in vitro experiments to identify conditions that induce a canonical T_RM phenotype and found that that naïve and newly activated CD8 T cells maintain CD103 expression during culture with transforming growth factor-beta (TGFβ), while central memory CD8 T cells (T_CM) do not express CD103 under similar conditions. In vivo experiments showed that the distribution of antiviral CTLs in the MLN changed when immune mice were treated with reagents that block interactions with PD-L1. Importantly, the lymphoid T_RM cells were poised for early proliferation upon reinfection with a different strain of IAV and defenses in the lungs were augmented by a transient increase in numbers of T_EFF cells at the site of infection. As the interval between infections increased, lymphoid T_RM cells were replaced with T_CM cells which proliferated with delayed kinetics and contributed to an exaggerated inflammatory response in the lungs.

Indiscriminate nature of lung resident CD8+ TRM cells reactivation and their varied reactivation profiles

CD8+ tissue resident memory (TRM) cells are poised at the portals of infection and confer immediate protection upon reinfection. Despite the critical role of CD8+ TRM cells in long-term protective immunity, the precise mechanics governing their reactivation in-situ are unclear. Seminal work by Leo Lefrançois' group showed that circulating (TCIRC) memory CD8+ T cell depends on CD11c+ antigen-presenting cells (APCs) for reactivation, however, TRM cells are reactivated within peripheral tissues, raising the question of whether the same principle is conserved. We examined this question, focusing on influenza infection, because APCs in the lung are well-defined and lung-resident TRM cells are critical for heterologous immunity to influenza. Using a TCR transgenic Nur77 reporter to delineate TCR-specific from bystander activation in CD8+ TRM cells, we characterized the superior reactivation kinetics in CD8+ TRM cell compared to CD8+ TCIRC. We also identified unique TCR-specific signatures and bystander-specific signatures in the kinetics of CD8+ TRM cells and TCIRC cells reactivation respectively. While we observed the strict requirement for CD11c+APCs in TCR-driven CD8+ TCIRC reactivation, CD8+ TRM cells exhibit promiscuity in their interactions with antigen-presenting partners in that they can be reactivated by both hematopoetic and non-hematopoetic cells. This study explains how the anatomical location of CD8+ TRM cells can confer unique advantage by demonstrating their superior reactivation kinetics and the indiscriminate nature of CD8+ TRM cell reactivation as well as showcasing the transcription profiles of TRM and TCIRC cells following different modes of activation.

Smad signaling determines the fate of activated CTLs via multiple intersecting signaling pathways

Immune responses to an infection are controlled by various factors including antigens, co-stimulatory molecules and cytokines present in the tissue micro-environment. These factors modulate the differentiation of effector CD8 T cells and memory subsets. TGFβ plays a pivotal role in fate determination of activated CTLs. In TGFβ pathway, Smad proteins are critical for downstream signaling. Using transgenic animal models and pharmacological inhibitors, we investigate the role of TGFβ and Smad proteins in fate determination of activated CTLs. We identified that TGFβ and Smad proteins play important roles in regulating the expression of several homing receptors on effector CD8 T cells (KLRG1) and memory subsets (CD62L, S1PR1 and CD103). In addition, targeted-ablation of different Smad proteins alter the expression levels of different transcription factors that participate in fate determination, including Eomes and KLF2. We found that while Smad proteins regulate the gene expression in canonical TGFβ pathway, they also have TGFβ independent functions in determining the fate of activated CTLs. Particularly, we show that Smad4 is required for the expression of KLRG1 and acts as a suppressor of CD103, independent of TGFβ. This study reveals a novel role for Smad signaling cascade in guiding the fate decisions of activated CTLs and tissue localization via multiple intersecting signaling pathways.

SMAD4-deficient Dendritic Cells in the Murine Lung shows an Activated Phenotype

SMAD4 is a signaling intermediate that acts downstream of the TGFb receptor. This signaling pathway is known to regulate expression of the Itgae gene (CD103) in activated CD8 T cells. Whether SMAD4 plays a role in induction or maintenance of CD103+ dendritic cells (DCs) has not been investigated. To address this question, we crossed SMAD4 floxed mice with Cre under the control of the CD11c promoter. DCs in the lung, spleen and bone marrow of naïve CD11c-SMAD4 mice were analyzed by multi-parameter flow cytometry. The lungs of Smad4-deficient mice contained smaller numbers of CD11c+ cells than control animals, and the remaining cells expressed costimulatory molecules and CD11b at high levels. Lung suspensions were metal barcoded for time of flight cytometry (cyTOF) and viSNE maps were contracted using 25 parameters. Under these homeostatic conditions, Smad4-abalation caused a dramatic decrease in CD11c+ DCs with activation of pSTAT5, when compared to DCs from littermate controls. Activation of pSTAT5 in KO was specific to CD11c+ DCs as no difference was seen in other cell types including T cells. Our data indicate that the lungs of SMAD4-CD11c KO mice were depleted of migratory DCs, which migrated to the draining lymph nodes after spontaneous maturation. We currently are exploring whether DC-depletion undermines cell mediated immunity to respiratory virus infection.

Environmental cues orchestrate regional immune surveillance and protection by pulmonary CTLs

Tissue-resident memory CD8 T cells (T_RM) provide preemptive immunity against infections that begin in peripheral tissues by guarding the site of initial pathogen exposure. Their role in immunity to respiratory virus infection is particularly important because severe damage to the alveoli can be avoided when local populations of T_RM cells reduce viral burdens and dampen the responses of effector CD8 T cells in the lungs. Although a connection between rapid immune activation and early viral control is well established, the signals that keep T_RM cells poised for action in the local tissues remain poorly defined. Recent studies have shown that environmental cues influence the fate decisions of activated CTLs during memory formation. Manipulation of these signaling pathways could provide new ways to capitalize on protection from T_RM cells in mucosal tissues, while reducing collateral damage and pathology during vaccination.

Smad4 Signaling is Important for Generation of Teff Cells but not Protection

Ideally, vaccines for pulmonary infections should generate protective populations of anti-viral memory CD8 T cells without accompanying responses by pathogenic effector T (Teff) cells. With this goal in mind, we examined the influence of transforming growth factor β (TGFβ), and the downstream molecule Smad4, during CD8 T cell differentiation. CTLs lacking the TGFβ receptor preferentially expressed KLRG1 after influenza virus infection indicating the presence of highly differentiated Teff cells, while differentiation of CD103+ tissue resident memory T (Trm) cells was completely abrogated. In contrast, Smad4-deficient CD8 T cells preferentially acquired a KLRG1-negative phenotype, while CD103 was aberrantly expressed on CTLs in other tissues. Smad4-deficency caused slightly delayed viral clearance after primary IAV infection, but was not required for protective immunity upon reinfection with another strain. Our data indicate that Smad4 dictates the fate decision of activated CTLs by integrating signals from multiple environmental stimuli to promote TEFF generation.

Costimulation Endows Immunotherapeutic CD8 T Cells with IL-36 Responsiveness during Aerobic Glycolysis

CD134- and CD137-primed CD8 T cells mount powerful effector responses upon recall, but even without recall these dual-costimulated T cells respond to signal 3 cytokines such as IL-12. We searched for alternative signal 3 receptor pathways and found the IL-1 family member IL-36R. Although IL-36 alone did not stimulate effector CD8 T cells, in combination with IL-12, or more surprisingly IL-2, it induced striking and rapid TCR-independent IFN-γ synthesis. To understand how signal 3 responses functioned in dual-costimulated T cells we showed that IL-2 induced IL-36R gene expression in a JAK/STAT-dependent manner. These data help delineate a sequential stimulation process where IL-2 conditioning must precede IL-36 for IFN-γ synthesis. Importantly, this responsive state was transient and functioned only in effector T cells capable of aerobic glycolysis. Specifically, as the effector T cells metabolized glucose and consumed O2, they also retained potential to respond through IL-36R. This suggests that T cells use innate receptor pathways such as the IL-36R/axis when programmed for aerobic glycolysis. To explore a function for IL-36R in vivo, we showed that dual costimulation therapy reduced B16 melanoma tumor growth while increasing IL-36R gene expression. In summary, cytokine therapy to eliminate tumors may target effector T cells, even outside of TCR specificity, as long as the effectors are in the correct metabolic state.

Smad4 promotes differentiation of effector and circulating memory CD8 T cells but is dispensable for tissue-resident memory CD8 T cells

Tissue-resident memory CD8 T cells are a unique subset of virus-specific CTLs that bolster local immune responses after becoming lodged in previously infected tissues. These cells provide enhanced protection by intercepting returning pathogens before a new infection gets established. In contrast, central memory CD8 T cells circulate in the bloodstream and proliferate in secondary lymphoid organs before replenishing effector and memory CD8 T cell populations in remote parts of the body. Both populations of virus-specific memory CD8 T cells participate in immunity to influenza virus infection; however, the signaling pathways that instruct developing memory CD8 T cells to distribute to specific tissues are poorly defined. We show that TGF-β promotes the development of pulmonary tissue-resident memory T cells via a signaling pathway that does not require the downstream signaling intermediate Sma- and Mad-related protein (Smad)4. In contrast, circulating memory CD8 T cells have no requirement for TGF-β but show signs of arrested development in the absence of Smad4, including aberrant CD103 expression. These signaling pathways alter the distribution of virus-specific CTLs in the lungs but do not prevent robust cytokine responses. Our data show that Smad4 is required for normal differentiation of multiple subsets of virus-specific CD8 T cells. In normal circumstances, Smad4 may be activated via a pathway that bypasses the TGF-β receptor. Improved understanding of these signaling pathways could be used to augment vaccine-induced immunity.

Why is coinfection with influenza virus and bacteria so difficult to control?

Influenza viruses are genetically labile pathogens which avoid immune detection by constantly changing their coat proteins. Most human infections are caused by mildly pathogenic viruses which rarely cause life-threatening disease in healthy people, but some individuals with a weakened immune system can experience severe complications. Widespread infections with highly pathogenic strains of influenza virus are less common, but have the potential to cause enormous death tolls among healthy adults if infection rates reach pandemic proportions. Increased virulence has been attributed to a variety of factors, including enhanced susceptibility to coinfection with common strains of bacteria. The mechanisms that facilitate dual infection are a major focus of current research, as preventative measures are needed to avert future pandemics.

CD4+ T cell help guides formation of CD103+ lung-resident memory CD8+ T cells during influenza viral infection

Tissue-resident memory T (Trm) cells provide enhanced protection against infection at mucosal sites. Here we found that CD4(+) T cells are important for the formation of functional lung-resident CD8(+) T cells after influenza virus infection. In the absence of CD4(+) T cells, CD8(+) T cells displayed reduced expression of CD103 (Itgae), were mislocalized away from airway epithelia, and demonstrated an impaired ability to recruit CD8(+) T cells to the lung airways upon heterosubtypic challenge. CD4(+) T cell-derived interferon-γ was necessary for generating lung-resident CD103(+) CD8(+) Trm cells. Furthermore, expression of the transcription factor T-bet was increased in "unhelped" lung Trm cells, and a reduction in T-bet rescued CD103 expression in the absence of CD4(+) T cell help. Thus, CD4(+) T cell-dependent signals are important to limit expression of T-bet and allow for the development of CD103(+) CD8(+) Trm cells in the lung airways following respiratory infection.

Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection

Previous studies have shown that some respiratory virus infections leave local populations of tissue TRM cells in the lungs which disappear as heterosubtypic immunity declines. The location of these TRM cells and their contribution to the protective CTL response have not been clearly defined. Here, fluorescence microscopy is used to show that some CD103(+) TRM cells remain embedded in the walls of the large airways long after pulmonary immunization but are absent from systemically primed mice. Viral clearance from the lungs of the locally immunized mice precedes the development of a robust Teff response in the lungs. Whereas large numbers of virus-specific CTLs collect around the bronchial tree during viral clearance, there is little involvement of the remaining lung tissue. Much larger numbers of TEM cells enter the lungs of the systemically immunized animals but do not prevent extensive viral replication or damage to the alveoli. Together, these experiments show that virus-specific antibodies and TRM cells are both required for optimal heterosubtypic immunity, whereas circulating memory CD8 T cells do not substantially alter the course of disease.

Division of labor between subsets of lymph node dendritic cells determines the specificity of the CD8⁺ T-cell recall response to influenza infection

Cytotoxic T lymphocytes (CTLs) are important targets for vaccines against a wide variety of infections that enter the body via mucosal tissues. To induce effective immunity these vaccines must include the most protective epitopes and elicit rapid recall responses at the site of infection. Although live attenuated viruses are sometimes used to induce cellular immunity against recurrent influenza infections, the mechanisms that determine the magnitude of the response to individual viral components are very poorly defined. Heterosubtypic infections in C57BL/6 mice illustrate an additional level of complexity, when the antigen specificity of the response shifts dramatically between primary and secondary challenge. This model provides a unique opportunity to identify the mechanisms that regulate memory CD8(+) T-cell reactivation in vivo and control the specificity of the recall response by pathogen-specific CTL. We show that multiple factors contribute to the changing pattern of immunodominance during secondary infection, including the location of the memory CD8(+) T cells at the time of reinfection and their ability to directly recognize migratory CD103(+) DCs as they arrive in the lung draining LN.

Duration of antigen availability influences the expansion and memory differentiation of T cells

The initial engagement of the TCR through interaction with cognate peptide-MHC is a requisite for T cell activation and confers Ag specificity. Although this is a key event in T cell activation, the duration of these interactions may affect the proliferative capacity and differentiation of the activated cells. In this study, we developed a system to evaluate the temporal requirements for antigenic stimulation during an immune response in vivo. Using Abs that target specific Ags in the context of MHC, we were able to manipulate the duration of Ag availability to both CD4 and CD8 T cells during an active infection. During the primary immune response, the magnitude of the CD4 and CD8 T cell response was dependent on the duration of Ag availability. Both CD4 and CD8 T cells required sustained antigenic stimulation for maximal expansion. Memory cell differentiation was also dependent on the duration of Ag exposure, albeit to a lesser extent. However, memory development did not correlate with the magnitude of the primary response, suggesting that the requirements for continued expansion of T cells and memory differentiation are distinct. Finally, a shortened period of Ag exposure was sufficient to achieve optimal expansion of both CD4 and CD8 T cells during a recall response. It was also revealed that limiting exposure to Ag late during the response may enhance the CD4 T cell memory pool. Collectively, these data indicated that Ag remains a critical component of the T cell response after the initial APC-T cell interaction.

The migration of T cells in response to influenza virus is altered in neonatal mice

Influenza virus is a significant cause of mortality and morbidity in children; however, little is known about the T cell response in infant lungs. Neonatal mice are highly vulnerable to influenza and only control very low doses of virus. We compared the T cell response to influenza virus infection between mice infected as adults or at 2 d old and observed defective migration into the lungs of the neonatal mice. In the adult mice, the numbers of T cells in the lung interstitia peaked at 10 d postinfection, whereas neonatal T cell infiltration, activation, and expression of TNF-alpha was delayed until 2 wk postinfection. Although T cell numbers ultimately reached adult levels in the interstitia, they were not detected in the alveoli of neonatal lungs. Instead, the alveoli contained eosinophils and neutrophils. This altered infiltrate was consistent with reduced or delayed expression of type 1 cytokines in the neonatal lung and differential chemokine expression. In influenza-infected neonates, CXCL2, CCL5, and CCL3 were expressed at adult levels, whereas the chemokines CXCL1, CXCL9, and CCL2 remained at baseline levels, and CCL11 was highly elevated. Intranasal administration of CCL2, IFN-gamma, or CXCL9 was unable to draw the neonatal T cells into the airways. Together, these data suggest that the T cell response to influenza virus is qualitatively different in neonatal mice and may contribute to an increased morbidity.

CD69 and CD103 cooperatively regulate CD8 T cell responses in the lungs after viral infection (39.25)

T cell mediated immunity to influenza infection disappears within a few months, even though large numbers of virus-specific memory CD8 T cells remain in the circulation for at least two years. It has been suggested that antigen persistence may play an instrumental role in protective cellular immunity. This idea is supported by the presence of activated virus-specific CD8 T cells in the respiratory tract during the months following infection, when processed influenza antigens are presented to virus-specific CD8 T cells in the draining lymph nodes. A majority of the endogenous virus-specific CD8 T cells that were at the mucosal surface of the lungs one month after infection expressed both CD69 and CD103. In contrast, bystander memory CD8 T cells that entered the lungs during parabiosis did not acquire this phenotype. We have crossed CD69KO and CD103KO mice with F5 TcR transgenic mice which are specific for the influenza NP peptide. Transfer studies show that CD103-deficiency results in reduced numbers of CD69+ NP-specific CD8 T cells in the lungs. In contrast, CD69-deficiency results in slightly delayed T cell activation followed by a late accumulation of CD103-negative NP-specific CD8 T cells in the lung parenchyma. This work was supported by NIH grants AI065895 & AI071213 (LSC), RO1 AI-36532 (GH).

Evidence that prolonged antigen-driven inflammation after influenza infection helps shape the specificity of the CD8 T cell recall response (130.5)

Influenza viruses encode four major epitopes (NP, PA, PB1 and PB2) that are recognized by naïve CD8 T cells in C57BL/6 mice. MHC class I tetramer analysis has shown that CD8 T cells specific for the NP and PA epitopes are equally represented during the response to a primary infection with the reassortant HKx31 influenza virus. Secondary challenge with the serologically distinct A/PR/8 strain, however leads to a change in the dominance hierarchy so that NP-specific cells outnumber PA-specific cells in most tissues by approximately 5:1. We recently found that processed NP antigen persists in vivo long after infectious influenza virus has been eliminated. Large numbers of endogenous NP-specific CD8 T cells in the antigen bearing lymph nodes showed signs of a response to recent antigen stimulation. In contrast, there were much smaller numbers of PA-specific CD8 T cells in the mediastinal lymph node (MLN), with a much lower frequency of activated T cells. Since DC carry viral antigens to the MLN immediately after influenza infection, we have investigated whether the local specificities of antigen-specific memory CD8 T cells in the MLN at the time of reinfection help shape the specificity of the recall response. Since there is evidence in the literature that NP epitope is more protective than PA epitope, these studies will help us to elucidate the role of antigen and the biology of local specific memory CD8 T cell response in the shaping of the CD8 T cell response during secondary infections with influenza virus. This work was supported by NIH grants AI065895 & AI071213 (LSC),

In situ imaging reveals different responses by naïve and memory CD8 T cells to late antigen presentation by lymph node DC after influenza virus infection

Pulmonary influenza infection causes prolonged lymph node hypertrophy while processed viral antigens continue to be presented to virus-specific CD8 T cells. We show that naïve, but not central/memory, nucleoprotein (NP)-specific CD8 T cells recognized antigen-bearing CD11b(+) DC in the draining lymph nodes more than 30 days after infection. After these late transfers, the naïve CD8 T cells underwent an abortive proliferative response in the mediastinal lymph node (MLN), where large clusters of partially activated cells remained in the paracortex until at least a week after transfer. A majority of the endogenous NP-specific CD8 T cells that were in the MLN between 30 and 50 days after infection also showed signs of a continuing response to antigen stimulation. A high frequency of endogenous NP-specific CD8 T cells in the MLN indicates that late antigen presentation may help shape the epitope dominance hierarchy during reinfection.

In situ visualization of CD8 T cell-DC interactions reveals distinct features of the early and late response to antigen after influenza virus infection (87.27)

The anatomical characteristics of T cell activation following infection are poorly described. Using transferred CD8 T cells and confocal microscopy we show that small clusters of virus-specific T cells formed transiently in the lung-draining lymph nodes (DLN) early in the response to influenza virus infection. Several weeks after infection naïve nucleoprotein (NP)-specific CD8 T cells still responded to antigen in the DLN, but remained predominantly in large stable clusters that included CD11c+ APCs. Many activated cells upregulated CD69 and PD-1, but did not lose CD62L-expression and remained clustered with CD11c+ APCs in the paracortex of the DLN until at least 7 days after transfer. Some central/memory cells also entered the DLN after transfer, but did not colocalize with the clustered naïve cells or show any signs of a response to the antigen. These data indicated a change in the response to antigen stimulation in the DLN as the time interval after infection increased and suggested that naïve and memory F5 CD8 T cells used different mechanisms to locate antigen-bearing APCs within the pLN. Some endogenous NP366-374/Db-specific CD8 T cells were also retained in the MLN and showed signs of a continuing response to antigen stimulation, while PA324-332/Db-specific cells were predominantly found in non-lymphoid tissues. Overall all the data revealed a dichotomy in the response to late antigen presentation which could influence epitope selection during reinfection by favoring preferential expansion of the NP366-374/Db-specific cells in the DLN.

This work was supported by the American Lung Association RG1119 (L.S.C.), the Damon Runyon foundation (K.M.K.) and National Institutes of Health grants; R21-AI065895 (L.S.C.) and DK45260, AI41576 and AI56172 (LL).

Persistent antigen presentation after acute vesicular stomatitis virus infection

Long-term antigen expression is believed to play an important role in modulation of T-cell responses to chronic virus infections. However, recent studies suggest that immune responses may occur late after apparently acute infections. We have now analyzed the CD8 T-cell response to vesicular stomatitis virus (VSV), which is thought to cause to an infection characterized by rapid virus clearance by innate and adaptive immune system components. Unexpectedly, virus-encoded antigen was detectable more than 6 weeks after intranasal VSV infection in both draining and nondraining lymph nodes by adoptively transferred CD8 T cells. Infection with Listeria monocytogenes expressing the same antigen did not result in prolonged antigen presentation. Weeks after VSV infection, discrete T-cell clustering with dendritic cells within the lymph node was observed after transfer of antigen-specific CD8 T cells. Moreover, memory CD8 T cells as defined by phenotype and function were generated from naïve CD8 T cells entering the response late after infection. These findings suggested that protracted antigen presentation after an apparently acute virus infection may contribute to an ongoing antiviral immune response.

Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs

Secondary lymphoid organs (SLOs) promote primary immune responses by recruiting naive lymphocytes and activated APCs. However, their role in the persistence or responsiveness of memory lymphocytes is unclear. We tested whether memory cells were maintained and could respond to challenge in the absence of SLOs. We found that influenza-specific CD8 cells in the lung acquired a memory phenotype, underwent homeostatic proliferation, recirculated through nonlymphoid tissues, and responded to and cleared a challenge infection in the complete absence of SLOs. Similarly, influenza-specific virus-neutralizing antibody was generated and maintained in the absence of SLOs. Inducible bronchus-associated lymphoid tissue (iBALT) was also formed in the lungs of previously infected mice and may provide a niche for the maintenance of memory cells at the local level. These data show that SLOs are dispensable for the maintenance of immunologic memory and directly demonstrate the utility of local tissues, such as iBALT, in secondary immune responses.

Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration

Activated virus-specific CD8 T cells remain in the lung airways for several months after influenza virus infection. We show that maintenance of this cell population is dependent upon the route of infection and prolonged presentation of viral antigen in the draining lymph nodes (DLN) of the respiratory tract. The local effects on T cell migration have been examined. We show retention of virus-specific CD8 T cells in the mediastinal lymph node (MLN) and continuing recruitment of blood-borne migrants into the lung airways during antigen presentation. These data show that antigen that is retained after pulmonary influenza virus infection controls the migratory pattern and activation state of virus-specific CD8 T cells near the site of virus amplification.

Dendritic cells maximize the memory CD8 T cell response to infection

Costimulatory signals from dendritic cells (DCs) are required for naive T cells to respond to antigenic stimulation. To what extent DCs reactivate memory T cells during recall responses is not known. Here, an in vivo depletion system has been used to analyze the role of DCs in reactivating CD8 memory T cells during recall responses to three different microbial infections. We show a profound decrease in the numbers of responding memory CD8 T cells in both lymphoid and nonlymphoid tissues during the recall responses to infection with vesicular stomatitis virus, Listeria monocytogenes (Lm), or influenza virus. These data show that interaction with DCs is a major mechanism driving T cell reactivation in vivo, even during a tissue-specific infection of the respiratory tract.

Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo

Lymphocyte activation gene-3 (LAG-3) is a CD4-related, activation-induced cell surface molecule that binds to MHC class II with high affinity. In this study, we used four experimental systems to reevaluate previous suggestions that LAG-3(-/-) mice had no T cell defect. First, LAG-3(-/-) T cells exhibited a delay in cell cycle arrest following in vivo stimulation with the superantigen staphylococcal enterotoxin B resulting in increased T cell expansion and splenomegaly. Second, increased T cell expansion was also observed in adoptive recipients of LAG-3(-/-) OT-II TCR transgenic T cells following in vivo Ag stimulation. Third, infection of LAG-3(-/-) mice with Sendai virus resulted in increased numbers of memory CD4(+) and CD8(+) T cells. Fourth, CD4(+) T cells exhibited a delayed expansion in LAG-3(-/-) mice infected with murine gammaherpesvirus. In summary, these data suggest that LAG-3 negatively regulates T cell expansion and controls the size of the memory T cell pool.

Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin

Following activation within secondary lymphoid tissue, CD8 T cells must migrate to targets, such as infected self tissue, allografts, and tumors, to mediate contact-dependent effector functions. To test whether the pattern of migration of activated CD8 T cells was dependent on the site of Ag encounter, we examined the distribution of mouse Ag-specific CD8 T cells following local challenges. Our findings indicated that activated CD8 T cells migrated pervasively to all nonlymphoid organs irrespective of the site of initial Ag engagement. Using an adoptive transfer system, migration of nonlymphoid memory cells was also examined. Although some limited preference for the tissue of origin was noted, transferred CD8 memory T cells from various nonlymphoid tissues migrated promiscuously, except to the intestinal mucosa, supporting the concept that distinct memory pools may exist. However, regardless of the tissue of origin, reactivation of transferred memory cells resulted in widespread dissemination of new effector cells. These data indicated that recently activated primary or memory CD8 T cells were transiently endowed with the ability to traffic to all nonlymphoid organs, while memory cell trafficking was more restricted. These observations will help refine our understanding of effector and memory CD8 T cell migration patterns.

Renewal of peripheral CD8+ memory T cells during secondary viral infection of antibody-sufficient mice

Kinetic studies and short pulses of injected 5-bromo-2-deoxyuridine have been used to analyze the development and renewal of peripheral CD8(+) memory T cells in the lungs during primary and secondary respiratory virus infections. We show that developing peripheral CD8(+) memory T cells proliferate during acute viral infection with kinetics that are indistinguishable from those of lymphoid CD8(+) memory T cells. Secondary exposure to the same virus induces a new round of T cell proliferation and extensive renewal of the peripheral and lymphoid CD8(+) memory T cell pools in both B cell-deficient mice and mice with immune Abs. In mice with virus-specific Abs, CD8(+) T cell proliferation takes place with minimal inflammation or effector cell recruitment to the lungs. The delayed arrival of CD8(+) memory T cells to the lungs of these animals suggests that developing memory cells do not require the same inflammatory signals as effector cells to reach the lung airways. These studies provide important new insight into mechanisms that control the maintenance and renewal of peripheral memory T cell populations during natural infections.

Nonspecific recruitment of memory CD8+ T cells to the lung airways during respiratory virus infections

Previous studies have shown that heterologous viral infections have a significant impact on pre-existing memory T cell populations in secondary lymphoid organs through a combination of cross-reactive and bystander effects. However, the impact of heterologous viral infections on effector/memory T cells in peripheral sites is not well understood. In this study, we have analyzed the impact of a heterologous influenza virus infection on Sendai virus-specific CD8(+) effector/memory cells present in the lung airways. The data show a transient increase in the numbers of Sendai virus nucleoprotein 324-332/K(b)-specific CD8(+) memory T cells in the airways of the influenza-infected mice peaking around day 4 postinfection. Intratracheal transfer studies and 5-bromo-2'-deoxyuridine incorporation demonstrate that this increase is due to the recruitment of resting memory cells into the airways. In addition, the data show that these immigrating memory cells are phenotypically distinct from the resident memory T cells of the lung airways. A similar influx of nonproliferating Sendai virus nucleoprotein 324-332/K(b)-specific CD8(+) memory T cells is also induced by a secondary (homologous) infection with Sendai virus. Together, these data suggest that inflammation can accelerate memory T cell migration to nonlymphoid tissues and is a part of the normal recall response during respiratory infections.

Reliable generation and use of MHC class II:gamma2aFc multimers for the identification of antigen-specific CD4(+) T cells

MHC tetramers have proven to be powerful reagents for the analysis of MHC class I-restricted T cells. However, generating similarly reliable reagents for MHC class II-restricted T cells has been elusive. Here we evaluated the utility of MHC class II:gamma2aFc multimers, which contain the MHC class II extracellular domains, with or without recombinantly attached peptides, dimerized via a fos-jun leucine zipper and attached to the hinge of murine IgG2a. We have successfully generated 24 multimers in either myeloma or Drosophila melanogaster S2 cells, with an average yield of 7 mg/L. 'Empty' MHC class II:gamma2aFc multimers were effectively used in peptide binding assays. Similar versions that contained recombinantly attached peptides stimulated T cells in an antigen-specific, MHC-restricted manner, and identified antigen-specific nai;ve and effector T cells by flow cytometry. Furthermore, we have successfully used these reagents to stain T cells generated following viral infection. Thus, MHC class II:gamma2aFc multimers are robust and reliable reagents for the analysis of MHC class II-restricted T cells.

Cutting edge: virus-specific CD4+ memory T cells in nonlymphoid tissues express a highly activated phenotype

Recent studies have shown that CD4(+) memory T cells persist in nonlymphoid organs following infections. However, the development and phenotype of these peripheral memory cells are poorly defined. In this study, multimerized MHC-Ig fusion proteins, with a covalently attached peptide sequence from the Sendai virus hemagglutinin/neuraminidase gene, have been used to identify virus-specific CD4(+) T cells during Sendai virus infection and the establishment of peripheral CD4(+) memory populations in the lungs. We show declining frequencies of virus-specific CD4(+) T cells in the lungs over the course of approximately 3 mo after infection. Like peripheral CD8(+) T cells, the CD4(+) have an acutely activated phenotype, suggesting that a high level of differentiation is required to reach the airways and persist as memory cells. Differences in CD25 and CD11a expression indicate that the CD4(+) cells from the lung airways and parenchyma are distinct memory populations.

Long-term maintenance of virus-specific effector memory CD8+ T cells in the lung airways depends on proliferation

Recent studies have shown that virus-specific effector memory T cells can be recovered from the lung airways long after clearance of a respiratory virus infection. These cells are thought to play an important role in the recall response to secondary viral infection. It is currently unclear whether these cells actually persist at this site or are maintained by continual proliferation and recruitment. In this study, we have analyzed the mechanisms underlying the persistence of memory CD8(+) T cells in the lung airway lumina following recovery from a respiratory virus infection. The data identify two distinct populations of memory cells. First, a large population Ag-specific CD8(+) T cells is deposited in the airways during the acute response to the virus. These cells persist in a functional state for several weeks with minimal further division. Second, a smaller population of Ag-specific CD8(+) T cells is maintained in the lung airways by homeostatic proliferation and migration to lung airways after viral clearance. This rate of proliferation is identical to that observed in the spleen, suggesting that these cells may be recent immigrants from the lymphoid organs. These data have significant implications for vaccines designed to promote cellular immunity at mucosal sites such as the lung.

Antiviral memory T-cell responses in the lung

Recent studies have identified distinct populations of memory T cells that persist in the lungs following respiratory virus infections, and contribute to the control of secondary virus infections. Here we discuss the establishment, maintenance and recall of memory T cells in the lung.

Memory T-cells in non-lymphoid tissues

Recent studies have shown that long-lived memory CD8 T-cell populations can be subdivided into two distinct groups. The central pool of resting memory cells in lymph organs has been extensively analyzed. However, a second subset of partially activated CD8 memory T-cells has recently been identified in non-lymphoid tissues. In respiratory virus models, a strong correlation between the numbers of antigen-specific T-cells in lung tissues and effective protective cellular immunity suggests that boosting the numbers of memory T-cells in non-lymphoid tissues may be a fruitful approach in vaccine development for viral infections.

Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma

We have previously shown that systemic staphylococcal enterotoxin A (SEA) injections cause CD4 T cells in TCR-transgenic mice to become tolerant to subsequent ex vivo restimulation. An active IFN-gamma-dependent mechanism of suppression was responsible for the apparent unresponsiveness of the CD4 T cells. In this study, we analyze the response of CD4 T cells isolated throughout the first 10 days of the in vivo response to injected SEA. We show that CD4 T cells isolated at the peak of the in vivo response undergo very little activation-induced cell death after sterile FACS sorting or restimulation in the presence of neutralizing Abs to IFN-gamma. We also show that the IFN-gamma-dependent tolerance develops soon after SEA injection in the spleens of both normal and TCR-transgenic mice. This suppression is dependent upon myeloid cells from the SEA-treated mice and is optimal when inducible NO synthase activity and reactive oxygen intermediates are both present. The data indicate that IFN-gamma, myeloid cells, and a combination of NO and reactive oxygen intermediates all contribute to a common pathway of T cell death that targets activated or responding CD4 T cells. Sorted Gr-1(+) cells from SEA-treated mice also directly suppress the response of naive CD4 T cells in mixed cultures, indicating that this tolerance mechanism may play a role in down-regulating other vigorous immune responses.

Transferable anergy: superantigen treatment induces CD4+ T cell tolerance that is reversible and requires CD4-CD8- cells and interferon gamma

Bacterial superantigens induce peripheral unresponsiveness in CD4+ T cell populations that express appropriate Vbeta chains. We have used Vbeta3/Valpha11 T cell receptor transgenic (Tg) mice and the Vbeta3-specific superantigen staphylococcal enterotoxin A (SEA) to further investigate the mechanisms that contribute to such unresponsiveness. As in other models, in vivo exposure to SEA rendered the Tg CD4+ cells unresponsive to subsequent restimulation in vitro with antigen or mitogens. However, when the SEA-treated CD4+ cells were completely purified away from all other contaminating cells, they regained the ability to proliferate and secrete cytokines. Moreover, enriched CD4-CD8- cells from the SEA-treated mice suppressed the responses of fresh control CD4+ cells in mixed cultures indicating that the apparent "anergy" was both transferable and reversible. Further analysis demonstrated that interferon gamma, but not the Fas receptor, played a critical role in the suppression.

Evidence for an early heavy chain intermediate in the assembly of H-2Db class I MHC molecules

Several recently proposed models for the in vivo biogenesis of class I MHC molecules focus on the retention of empty dimers as a postulated intermediate in the assembly of the complete complexes. The data presented in this study support a slightly different model of class I biogenesis, which includes a precursor population of H-2Db heavy chains (HCs) that is retained in the ER of murine cells prior to its association with beta-2 microglobulin (beta 2m). For this study the intracellular ratios of the subunits that comprise class I molecules have been manipulated to generate a transfected cell line which assembles only very small numbers of unstable H-2Db molecules. Immunoprecipitation experiments with this transfected cell line demonstrated that nascent beta 2m was assembled into complete H-2Db heterotrimers more rapidly than nascent H-2Db HCs by normal murine cells. These data were not consistent with the simultaneous retention of the two associated subunits (HC and beta 2m) in a pool of precursor molecules. However, a previously uncharacterized subset of immature H-2Db HCs, which were not associated with beta 2m, has been detected. These immature HCs exhibited several characteristics of a precursor to complete class I molecules and required a supply of endogenously synthesized peptides for their normal processing in vivo.